Tempus AI
Precision medicine company using AI and genomics to advance cancer care and personalized treatment. Publicly traded on NASDAQ (TEM). Operates one of the world's largest clinical and molecular databases.
Website
https://www.tempus.comLocation
Chicago, Illinois, USA
Founded
2015
Investors
7
Categories
genomics-sequencing, ai-drug-discovery, healthcare-platform, diagnostics, public-company, precision-medicine
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| NEA (New Enterprise Associates) | Menlo Park, California, USA | generalist | seedseries-a+3 | 1 |
| Revolution Growth | Washington, DC, USA | generalist | series-bseries-c+1 | 1 |
| SoftBank Vision Fund | Tokyo, Japan & London, UK | generalist | series-bseries-c+1 | 2 |
| GV (Google Ventures) | Mountain View, California, USA | cvc | seedseries-a+3 | 3 |
| Baillie Gifford | Edinburgh, UK | generalist | series-cgrowth | 1 |
| T. Rowe Price | Baltimore, Maryland, USA | hedge-fund | growth | 1 |
| Franklin Templeton Investments | San Mateo, California, USA | generalist | growth | 1 |